About Index Trending news
Analyze
Pricing
Eleven Biotherapeutics

Eleven Biotherapeutics

Eleven Biotherapeutics

Eleven Biotherapeutics is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.

Elsewhere

Alexa global traffic share

25 Nov 2014
$20,000,000
Post-IPO equity
09 Mar 2010
$35,000,000
Venture capital (Series A)